NewAmsterdam Pharma Company
NAMS
#4327
Rank
S$2.47 B
Marketcap
$22.55
Share price
-7.14%
Change (1 day)
-22.02%
Change (1 year)

EPS for NewAmsterdam Pharma Company (NAMS)

EPS in 2022: -$1.37

According to NewAmsterdam Pharma Company's latest financial reports the company's current EPS (TTM) is -$1.37. In 2022 the company made an earnings per share (EPS) of -$1.37 a decrease over its 2021 EPS that were of -$0.53.

EPS history for NewAmsterdam Pharma Company from 2020 to 2022

Annual EPS

Year EPS Change
2022-$1.37158.9%
2021-$0.53358.03%
2020-$0.12